Mirae Asset Global ETFs Holdings
RNAM

Mirae Asset Global ETFs Holdings’s Avidity Biosciences RNAM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-97,417
Closed -$7.03M – 3170
2025
Q4 		$7.03M Sell
97,417
-25,182
-21% -$1.63M 0.01% 711
2025
Q3 		$5.33M Sell
122,599
-14,710
-11% -$595K 0.01% 794
2025
Q2 		$3.9M Sell
137,309
-6,496
-5% -$194K 0.01% 812
2025
Q1 		$4.26M Sell
143,805
-765
-0.5% -$23.8K 0.01% 810
2024
Q4 		$4.2M Sell
144,570
-34,920
-19% -$1.46M 0.01% 826
2024
Q3 		$8.22M Sell
179,490
-4,551
-2% -$197K 0.02% 617
2024
Q2 		$7.52M Buy
+184,041
New +$5.28M 0.02% 625

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RNAM Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 97,417 shares — an estimated $7.03M sold.

Mirae Asset Global ETFs Holdings first reported a position in RNAM in Q2 2024 and held it in 7 quarters. The position peaked at $8.22M in Q3 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 97,417 Avidity Biosciences shares in Q1 2026, an estimated $7.03M.
  • Mirae Asset Global ETFs Holdings first reported a position in Avidity Biosciences in Q2 2024 and held it in 7 quarters.
  • Mirae Asset Global ETFs Holdings's Avidity Biosciences position peaked at $8.22M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.